普洛药业发布前三季度业绩，归母净利润7亿元，下降19.48%

Core Viewpoint - Pro Pharmaceutical (000739.SZ) reported a decline in revenue and net profit for the first three quarters of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for the first three quarters was 7.764 billion yuan, a year-on-year decrease of 16.43% [1] - The net profit attributable to shareholders was 700 million yuan, down 19.48% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 647 million yuan, reflecting a year-on-year decrease of 22.14% [1] - Basic earnings per share were 0.6063 yuan [1]